Re: Dynavax Presents Phase 2 Data on SD-101 in Combination with KEYTRUDA®
"Why would DVAX announce discontinuation of their cancer program if there was interest in it from another company? I don't know why people are contemplating this. "
Money pure and simple. they cannot afford to spend another $ on this program. They have advanced it enough to show that it has promise, actually more than promise. And now they need to sell it, stop the bleeding and raise cash, to pay off debt. An analogy might be a homebuilder who sells a home not completely finished to raise cash. House is framed, electrical and plumbing in. The buyer simply needs to finish it. But its at the stage where any pros[ectve buyer can visualize the potential, the finished product.
So yeah, they will sell it at a big discount, but on the other side they forgo having to spend $100sM, to bring it to the finish line, money that if spent would likely bankrupt them. makes perfect sense.